AC Immune SA Debt-to-Equity Ratio Growth & History (ACIU)

AC Immune SA's debt-to-equity ratio was 0.10 for fiscal 2025.

View full AC Immune SA company overview

AC Immune SA annual debt-to-equity ratio history

AC Immune SA annual debt-to-equity ratio

Fiscal yearPeriod endedDebt-to-equity ratioChangeGrowth
20252025-12-310.100.05+109.30%
20242024-12-310.050.03+122.06%
20232023-12-310.020.01+31.34%
20222022-12-310.020.00+32.13%
20212021-12-310.010.00+21.59%
20202020-12-310.010.00+24.64%
20192019-12-310.01−0.00−32.71%
20182018-12-310.010.01+618.64%
20172017-12-310.00

AC Immune SA debt-to-equity ratio trends

Over the last five fiscal years, AC Immune SA's debt-to-equity ratio increased from 0.01 to 0.10, a change of 0.09. The latest reported quarter, Q2 2026, shows 0.12.

About the metric

What the debt-to-equity ratio means

The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.

Calculation and source

How debt-to-equity is calculated

TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review AC Immune SA source filings ↗

Community posts

It’s quiet here.

No posts about ACIU yet. Start the conversation.

Write the first post